根据乳腺密度查资格的种族差异在州级保险扩张后
Mattia A Mahmoud1, Sarah Ehsan1, Sara P Ginzberg2
1Department of Biostatistics, Epidemiology, & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
JAMA network open
|August 5, 2025
概括
宾夕法尼亚州的补充乳腺癌查法为黑人妇女提供了有限的资格,因为乳腺密度和风险估计较低. 这些标准显示黑人女性识别假阴性乳房造影的灵敏度较差,突出了乳腺癌查效率的潜在差异.
科学领域:
- 放射学 放射学是一门学科.
- 在瘤学瘤学.
- 公共卫生政策 公共卫生政策
背景情况:
- 密集的乳腺组织增加了假阴性乳房影像的风险.
- 补充查可能有利于女性有密集的乳房.
- 宾夕法尼亚州要求对补充乳腺癌查进行保险.
研究的目的:
- 评估宾夕法尼亚州法律的结果,要求为补充乳腺癌查提供保险.
- 为了评估黑人和白人妇女的资格和假阴性乳房扫描率.
主要方法:
- 对68,478名接受乳房扫描的女性 (黑人和白人,年龄在40-74岁) 的横截面研究.
- 基于乳腺密度和终身癌症风险的补充查资格的分析.
- 种族群体之间的假阴性乳房扫描率的比较.
主要成果:
- 与白人女性相比,较少的黑人女性符合补充查的资格标准.
- 这些标准表明,在黑人妇女中检测假阴性乳房图的灵敏度较低.
- 仅仅使用乳腺密度作为补充查建议,可能会导致不必要的磁共振成像转诊.
结论:
- 宾夕法尼亚州的补充查标准限制了识别患有假阴性乳房影像风险的妇女的能力,特别是黑人妇女.
- 这些标准可能不准确地反映黑人女性的乳腺癌风险,可能会加剧健康差异.
- 目前的补充查指南可能需要重新评估,以确保所有女性均等获得和有效.
相关概念视频
Standards of Care I
760
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
760
Bias in Epidemiological Studies
666
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
666
Comparing the Survival Analysis of Two or More Groups
279
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
279
Cancer Survival Analysis
445
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
445


